Quarterly report pursuant to Section 13 or 15(d)

Loss Per Share (Tables)

v3.23.1
Loss Per Share (Tables)
9 Months Ended
Mar. 31, 2023
Schedule of Common Stock Equivalents [Abstract]  
Schedule of common stock equivalents
    March 31,
2023
    March 31,
2022
 
Convertible Notes     9,341,825      
 
Options     3,232,112       2,996,264  
Warrants     41,103       78,555  
Total     12,615,040       3,074,819